Developing a Mechanistic Understanding of the Scientific Substantiation of Reduced Risk Tobacco Products

      Sep 4, 2013 - Sep 4, 2013
      Hotel Interlaken, Höheweg 74, 3800 Interlaken, Switzerland
      Developing and commercializing reduced risk tobacco products has been one of PMI’s top priorities for many years.  Underlying the development of these products is the need for scientific validation of the risk reduction potential of such products. In order to build greater awareness around our science, we would like to take the opportunity to share our research on toxicology and systems biology approaches with you in more detail.